KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Income from Non-Controlling Interests (2016 - 2018)

Historic Income from Non-Controlling Interests for Vertex Pharmaceuticals (VRTX) over the last 8 years, with Q4 2018 value amounting to -$25.4 million.

  • Vertex Pharmaceuticals' Income from Non-Controlling Interests fell 179427.05% to -$25.4 million in Q4 2018 from the same period last year, while for Sep 2019 it was -$25.4 million, marking a year-over-year decrease of 24838.09%. This contributed to the annual value of -$9.8 million for FY2018, which is 9430.14% up from last year.
  • According to the latest figures from Q4 2018, Vertex Pharmaceuticals' Income from Non-Controlling Interests is -$25.4 million, which was down 179427.05% from -$290000.0 recorded in Q3 2018.
  • Vertex Pharmaceuticals' 5-year Income from Non-Controlling Interests high stood at $28.4 million for Q2 2016, and its period low was -$188.3 million during Q3 2017.
  • Moreover, its 5-year median value for Income from Non-Controlling Interests was -$98000.0 (2015), whereas its average is -$10.7 million.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first surged by 574183.67% in 2016, then crashed by 2695675.29% in 2017.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Income from Non-Controlling Interests stood at $4.2 million in 2014, then plummeted by 122.39% to -$938000.0 in 2015, then crashed by 452.88% to -$5.2 million in 2016, then surged by 128.94% to $1.5 million in 2017, then tumbled by 1794.27% to -$25.4 million in 2018.
  • Its Income from Non-Controlling Interests was -$25.4 million in Q4 2018, compared to -$290000.0 in Q3 2018 and -$1.1 million in Q2 2018.